Financial Reports & Filings

2024

Financial Reports

Three Months Ended October 31, 2023:  MD&A and Financial Statements

2023

Financial Reports

Twelve Months Ended July 31, 2023: MD&A and Financial Statements

Three and Nine Months Ended April 30, 2023: MD&A and Financial Statements

Three and Six Months Ended January 31, 2023:  MD&A and Financial Statements

Three Months Ended October 31, 2022:  MD&A and Financial Statements

2022

Financial Reports

Twelve Months Ended July 31, 2022: MD&A and Financial Statements

Nine Months Ended April 30, 2022: MD&A and Financial Statements

Six Months Ended January 31, 2022: MD&A  and Financial Statements

Three Months Ended October 31, 2021:  MD&A and Financial Statements

Other Filings

2022 Annual Shareholder Meeting March 25, 2022: Management Information Circular and Form of Proxy

2021

Financial Reports

Twelve Months Ended July 31, 2021: MD&A and Financial Statements

Nine Months Ended April 30, 2021: MD&A and Financial Statements

Six Months Ended January 31, 2021: MD&A  and Financial Statements

Other Filings

CSE Filing Statement 

Sign up to receive the investor newsletter and stay informed of new press releases